April 19, 2023

AI-powered Imaging Device Tested at AdventHealth

AdventHealth News

Vipul Patel and his team using robotics during surgery. [Photo: AdventHealth News]

A new clinical research study, conducted in partnership between CytoVeris Inc. and AdventHealth in Central Florida, United States, will investigate the precision of using an Artificial Intelligence (AI)-powered imaging device during surgery to improve prostate cancer margin assessment. Called MarginASSURE, this device is expected to provide more precise surgical decision-making in real time as well as improve patient outcomes.

The study will focus on CytoVeris’ multispectral imaging capability for the intraoperative assessment of cancer margin during robotically assisted radical prostatectomy (RARP) surgery and will involve only U.S.-based surgeries at AdventHealth Celebration led by Vipul Patel, founder and medical director of the Global Robotics Institute at AdventHealth Celebration, and his team.

Patel is world-renowned for his contribution to the field of robotic-assisted surgery and is one of the most experienced robotic surgeons in the world, having personally performed more than 16,000 robotic prostatectomies.

Why It Matters

According to the American Cancer Society, prostate cancer is the most common cancer in American men, other than skin cancer, and nearly 35,000 are estimated to die from this disease each year.

Of the 288,000 men per year in the U.S. who are diagnosed with prostate cancer, approximately 90,000 of those patients undergo RARP surgery. Post-surgical positive margin rates are generally about 20 percent and can lead to complications and poorer patient outcomes.

How the Device Will Be Used

During the multi-year study, Patel will collaborate with CytoVeris in adapting and developing its imaging platform for prostate cancer margin assessment.

“In the operating room, every move is critical. Robotic devices are changing the way we [surgeons] operate by providing more precision, therefore better patient outcomes,” Patel said. “This study will attempt to demonstrate the capability of MarginASSURE and its ability to detect cancer in near-real time in a label-free manner through the development of advanced tissue characterization technologies that can identify cancer tissue, assess margins, and identify critical tissue structures.”

Vipul Patel is the founder and medical director of the Global Robotics Institute at AdventHealth Celebration. [Photo: AdventHealth News]

The CytoVeris system is based on a proprietary Multi-Spectral Tissue Auto-Fluorescence (AF) Imaging technology, which analyzes the “optical fingerprint” of tissue based on its intrinsic biomolecular and morphological characteristics without the use of dyes or imaging agents.

MarginASSURE, the prostate imaging device, is designed to provide the rapid margin assessment of excised prostate specimens and deliver to the surgeon actionable data to help guide the surgical steps required to better optimize patient outcomes and optimize nerve sparing.

The project work will incorporate and correlate pre-operative MRI imaging of tumors with the MarginASSURE imaging of RARP specimens suspect of extraprostatic/extracapsular extension of cancer into the periprostatic soft tissues.

“CytoVeris was founded on the vision that by leveraging advanced optical imaging and artificial intelligence, surgeons will have the ability to visualize cancer when it matters most — in the operating room,” Alan D. Kersey, president and CEO of CytoVeris, said. “This clinical research study aims to demonstrate and validate our technology in prostate cancer, opening doors to further optimize patient outcomes.”

The original version of this story was posted on the AdventHealth news site.

Comment

About the Author

AdventHealth News

Sign up for the newsletter

Get the latest Adventist news straight into your inbox.

Related

Featured article image
Regional News

A recent conference sought to create more awareness about disabilities, and discussed what local Adventist congregations can do to welcome more people.

November 19, 2026

Featured article image
Regional News

The North American Division Executive Committee voted to support initiatives that seek to underpin the work of local conferences across the territory.

November 16, 2026

Featured article image
News

Youth mental health treatment has surged since the COVID-19 pandemic. An expert from Loma Linda University Health discusses options for treatment and use of medication.

November 15, 2026

Featured article image
News

An offering appeal that began at the 2026 North American Division Annual Council has raised more than US$12,000 to date to support mission in the Canadian Arctic.

Comments

Leave a comment

We'll send a link to confirm it's you. New here? Your account is created when you confirm. Your address is never published.

Advertisement

Ouchita Hills College